EUVIMEDEUVIMED entdecken
MetaanalyseSystematische ÜbersichtOpen Access · CC BY-NC-ND 4.0

Mucinous histology is a negative predictor of neoadjuvant chemoradiotherapy for locally advanced rectal adenocarcinoma

Xiangwen Tan, Yiwei Zhang, Xiaofeng Wu, Qing Fang, Yunhua Xu, Shuxiang Li, Jinyi Yuan, Xiuda Peng, Kai Fu, Shuai Xiao

BMC Gastroenterology · 2024

DOI: 10.1186/s12876-024-03359-9 ↗

Kurz gefasst

Metaanalyse in der Zeitschrift BMC Gastroenterology, 2024. Verfasst von Xiangwen Tan und 9 weiteren Autor:innen. Beteiligte Einrichtung: The Second Affiliated Hospital, Department of Hepatobiliary Surgery, Hengyang Medical School, University of South China, Hengyang, 421001, Hunan, Chi…. Hauptthemen laut MEDLINE: Rectal Neoplasms, Neoadjuvant Therapy, Adenocarcinoma, Mucinous. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Natural Science Foundation of Hunan Province,China, Scientific Research Fund Project of Hunan Provincial Health Commission.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Neoadjuvant chemoradiotherapy (NCRT) followed by total mesorectal excision (TME) is the standard treatment for locally advanced rectal cancer (LARC). Mucinous adenocarcinoma (MAC) is a potential poor prognosis subgroup of rectal cancer. However, the predictive value of MAC in NCRT treatment of LARC is controversial. METHODS: A comprehensive literature search of PubMed, Embase, and the Cochrane Library was performed. All studies examining the effect of MAC on CRT response in LARC were included. Outcomes of MAC were compared with non-specific adenocarcinoma (AC) by using random-effects methods. Data were presented as odds ratios (ORs) with 95% confidence intervals (CIs). The main outcomes were the rates of pathological complete response (pCR), tumor and nodal down-staging, positive resection margin rate, local recurrence, and overall mortality. RESULTS: Fifteen studies containing comparative data on outcomes in a total of 9,238 patients receiving NCRT for LARC were eligible for inclusion. MAC had a reduced rate of pCR (OR, 0.38; 95% CI, 0.18-0.78) and tumor down-staging (OR, 0.31; 95% CI, 0.22-0.44) following NCRT compared with AC. MAC did not significantly affect nodal down-staging (OR, 0.42; 95% CI, 0.16-1.12) after NCRT. CONCLUSION: MAC of LARC was found to be a negative predictor of response to NCRT with lower rates of pCR and tumor down-staging for LARC. The nodal down-staging of MAC was relatively lower than that of AC, although the differences were not statistically significant.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Rectal NeoplasmsNeoadjuvant TherapyAdenocarcinoma, MucinousHumansNeoplasm StagingAdenocarcinomaNeoplasm Recurrence, LocalPrognosisTreatment OutcomeChemoradiotherapyChemoradiotherapy, AdjuvantMargins of Excision

Stichwörter der Autor:innen

Meta-analysisMucinous adenocarcinomaNeoadjuvant chemoradiotherapyRectal cancer

Autor:innen und Institutionen

  • The Second Affiliated Hospital, Department of Hepatobiliary Surgery, Hengyang Medical School, University of South China, Hengyang, 421001, Hunan, China.
  • The First Affiliated Hospital, Institute of Oncology, Hengyang Medical School, University of South China, Hengyang, 421001, Hunan, China.
  • The First Affiliated Hospital, Department of Gastrointestinal surgery, Hengyang Medical School, University of South China, Hengyang, 421001, Hunan, China.
  • The Second Affiliated Hospital, Department of Hepatobiliary Surgery, Hengyang Medical School, University of South China, Hengyang, 421001, Hunan, China. xiudapengusc@qq.com.
  • Institute of Molecular Precision Medicine and Hunan Key Laboratory of Molecular Precision Medicine, Department of General Surgery, Xiangya Hospital, Central South University, Changsha, 410008, Hunan, China. fu_kai@csu.e…
  • The First Affiliated Hospital, Institute of Oncology, Hengyang Medical School, University of South China, Hengyang, 421001, Hunan, China. xiaoshuai1982@hotmail.com.

Förderung

  • Natural Science Foundation of Hunan Province,China
  • Scientific Research Fund Project of Hunan Provincial Health Commission

Zitieren

APA

Tan, X., Zhang, Y., Wu, X., Fang, Q., Xu, Y., Li, S., Yuan, J., Peng, X., Fu, K., & Xiao, S. (2024). Mucinous histology is a negative predictor of neoadjuvant chemoradiotherapy for locally advanced rectal adenocarcinoma. BMC Gastroenterology. https://doi.org/10.1186/s12876-024-03359-9

Vancouver

Tan X, Zhang Y, Wu X, Fang Q, Xu Y, Li S, et al. Mucinous histology is a negative predictor of neoadjuvant chemoradiotherapy for locally advanced rectal adenocarcinoma. BMC Gastroenterology. 2024. doi:10.1186/s12876-024-03359-9

BibTeX
@article{Tan2024,
  author = {Tan, Xiangwen and Zhang, Yiwei and Wu, Xiaofeng and Fang, Qing and Xu, Yunhua and Li, Shuxiang and Yuan, Jinyi and Peng, Xiuda and Fu, Kai and Xiao, Shuai},
  title = {Mucinous histology is a negative predictor of neoadjuvant chemoradiotherapy for locally advanced rectal adenocarcinoma},
  journal = {BMC Gastroenterology},
  year = {2024},
  doi = {10.1186/s12876-024-03359-9}
}
Kostenlos starten →